Allarity Therapeutics, Inc. (ALLR) just unveiled an update.
Allarity Therapeutics, Inc. has amended its Senior Convertible Notes to limit the conversion of notes to common stock, restricting it to under 19.9% ownership without stockholder approval. This adjustment ensures compliance with market rules and maintains the current terms otherwise. Additionally, the company has updated its corporate presentation, providing fresh insights for investors and analysts on its website, reinforcing transparency and ongoing communication with the financial community.
See more insights into ALLR stock on TipRanks’ Stock Analysis page.
